Answer
Brentuximab vedotin (Adcetris) is indicated for adults with CD30-positive cutaneous T-cell lymphoma after at least one prior systemic therapy.
Sources for this answer
- Adcetris 50 mg powder for concentrate for solution for infusionTakeda UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 33Document updated
Sources checked